Investing

Seres Therapeutics : MCRB

MCRB

Stock Data

$16.94

$0.22 (1.28%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Seres Therapeutics Inc is at the forefront of developing microbiome therapeutics, focusing on restoring health by modulating the microbiome. Their leading product, SER-109, aims to treat recurrent Clostridioides difficile infection and has completed Phase III clinical trials. The company's pipeline also includes treatments for gastrointestinal infections and ulcerative colitis, among others. Through strategic partnerships, Seres Therapeutics is advancing research in microbiome technology for various diseases, including cancer. Founded in 2010 and based in Cambridge, Massachusetts, the company is pioneering in leveraging the microbiome for therapeutic purposes.

All Seres Therapeutics Articles

5 Articles

Trey Thoelcke | Apr 17, 2025 at 8:45 AM EDT

Stock Splits Matter: Here’s What’s Coming Up Soon

Here is a look at why companies split their stocks and why it matters. Plus, upcoming stock splits to watch…

Paul Ausick | Nov 28, 2023 at 8:37 AM EST

15 Companies That Had Their IPO in 2015: Best and Worst Performers

2015 was one of the worst years for IPOs in the past decade. Only 2016 and 2022 were worse. But…

Chris Lange | Aug 31, 2021 at 8:35 AM EDT

Cathie Wood’s ARK Invest Sells Over 840,000 Shares of Seres Therapeutics

One of Cathie Wood's ARK Invest exchange-traded funds sold over 840,000 shares of Seres Therapeutics on August 30.

Lee Jackson | Jul 23, 2021 at 8:42 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: American Airlines, Boston Beer, CarMax, Danaher, Domino’s, Monster, Starbucks and More

Friday's top analyst upgrades and downgrades included American Airlines, Boston Beer, CarMax, Danaher, Domino’s Pizza, D.R. Horton, Monster Beverage and…

Jon C. Ogg | Aug 11, 2020 at 9:12 AM EDT

Top Analyst Upgrades and Downgrades: Bed Bath & Beyond, Booking, Carvana, EA, EOG, Honeywell, ICE, Livongo, Nucor, Seres, Sunrun and More

Tuesday's top analyst upgrades and downgrades included Bed Bath & Beyond, Booking, Carvana, Electronic Arts, EOG Resources, Honeywell, Intercontinental Exchange,…